Abstract
Intellectual disabilities (ID) are lifelong conditions characterized by deficits in general intellectual functioning and adaptive skills with onset in the developmental period. Globally, the prevalence of ID varies by age and the prevalence in older adults is considerably lower than that in the general population indicating that people with ID (PWID) may have shorter life spans. Despite the substantially increased mean life expectancy compared to the past, PWID continue to experience poor care often dying twenty years earlier than others. Higher rates of mental illnesses, increased risk of physical health morbidity and mortality and advancing age worsen their health disadvantage. There is very limited evidence that the treatment needs of the elderly patient group with ID and a mental illness have either been described or addressed. We aimed to conduct a baseline audit and service evaluation describing the sociodemographic, clinical and treatment variables of elderly patients (aged over 65 years) attending a specialist out-patient psychiatry clinic for PWID, compliance with the suggested audit standards for this group, and make recommendations for future clinical practice. Results are presented in tabular form, with extensive psychiatric and physical health morbidity highlighted. Compliance with audit scores also suggested significant gaps in physical health care and monitoring. There is a need for close working relationships between the patient, carers, health and social care professionals at all levels to mitigate these issues and larger scale audits involving multiple centres are needed to further improve quality of service offered to this patient group.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Axmon, A., Björne, P., Nylander, L., & Ahlström, G. (2018). Psychiatric diagnoses in older people with intellectual disability in comparison with the general population: a register study. Epidemiology and Psychiatric Sciences, 27(5), 479–491. http://doi.org/https://doi.org/10.1017/S2045796017000051
Branford, D., Gerrard, D., Saleem, N., Shaw, C. and Webster, A., 2019. Stop** over-medication of people with an intellectual disability, autism or both (STOMP) in England part 2–the story so far. Advances in Mental Health and Intellectual Disabilities, 13(1), pp. 41–51.
Chauhan, U., Courtenay, K., & Hoghton, M. (2020). Physical health in people with intellectual disabilities. In S. Bhaumik & R. Alexander (Eds.), Oxford Textbook of the Psychiatry of Intellectual Disability (pp. 203–212). Oxford University Press, Oxford.
Chesney, E., Goodwin, G.M. and Fazel, S. (2014). Risks of all‐cause and suicide mortality in mental disorders: a meta‐review. World psychiatry, 13(2), 153–160.
Cilag, J., Abbott, E., & Center, G. (2001). Anticholinrgic effects of medication in elderly patients. Journal of Clinical Psychiatry, 62(21), 11–14.
Cooper, S.A (2019). Adults with Intellectual Disabilities and Psychiatric Diorders. In M. Scheepers & M. Kerr (Eds.), Seminars in the Psychiatry of Intellectual Disability (3rd Ed., pp. 125–135). Cambridge University Press.
Cooper, S. A. (2020). Types of mental disorders in people with intellectual disability. In S. Bhaumik & R. Alexander (Eds.), Oxford textbook of the psychiatry of intellectual disability (pp. 55–60). Oxford University Press.
Coppus, A. M. (2013). People with intellectual disability: what do we know about adulthood and life expectancy?. Developmental disabilities research reviews, 18(1), 6–16.
Das-Munshi, J., Chang, C. K., Dregan, A., Hatch, S. L., Morgan, C., Thornicroft, G., ... & Hotopf, M. (2021). How do ethnicity and deprivation impact on life expectancy at birth in people with serious mental illness? Observational study in the UK. Psychological Medicine, 51(15), 2581–2589.
Dening, T., & Thomas, A. (Eds.). (2013). Oxford textbook of old age psychiatry. Oxford University Press.
Deutsch, S. I., & Burket, J. A. (2021). Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 104, 110017.
Emerson, E., & Hatton, C. (2008). CEDR Research Report 2008 (1): People with Learning Disabilities in England.
Emerson, E., Baines, S., Allerton, L., & Welch, V. (2011). Health inequalities and people with learning disabilities in the UK.
Evenhuis, H. M., Hermans, H., Hilgenkamp, T. I., Bastiaanse, L. P., & Echteld, M. A. (2012). Frailty and disability in older adults with intellectual disabilities: results from the healthy ageing and intellectual disability study. Journal of the American Geriatrics Society, 60(5), 934–938.
Harris, J. C. (2006). Intellectual disability: Understanding its development, causes, classification, evaluation, and treatment. Oxford University Press.
Linehan, C (2019). Epidemiology of Intellectual Disability. In M. Scheepers & M. Kerr (Eds.), Seminars in the Psychiatry of Intellectual Disability (3rd Ed., pp. 1–11). Cambridge University Press.
MacRae, S., Brown, M., Karatzias, T., Taggart, L., Truesdale-Kennedy, M., Walley, R., ... & Davies, M. (2015). Diabetes in people with intellectual disabilities: a systematic review of the literature. Research in developmental disabilities, 47, 352–374.
McCarron, M., Swinburne, J., Burke, E., McGlinchey, E., Carroll, R., & McCallion, P. (2013). Patterns of multimorbidity in an older population of persons with an intellectual disability: results from the intellectual disability supplement to the Irish longitudinal study on aging (IDS-TILDA). Research in developmental disabilities, 34(1), 521–527.
National Institute for Health and Care Excellence, 2016. Mental Health problems in people with learning disabilities—prevention, assessment, and management [NG54]. Retrieved https://www.nice.org.uk/guidance/ng54 (Accessed 19 June 2023).
National Institute for Health and Care Excellence (2021). People with a learning disability. NICE Impact Report. https://www.nice.org.uk/Media/Default/Get-involved/Meetings-In-Public/Public-board-meetings/nov21-pbm-Learning-disability-impact-report.pdf
NHS Health Research Authority (2020) UK policy framework for health and social care research. https://s3.eu-west-2.amazonaws.com/www.hra.nhs.uk/media/documents/Final_Accessibility_uk-policy-framework-health-social-care-research_.pdf
O’Dwyer, M., McCallion, P., McCarron, M., & Henman, M. (2018). Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research. Therapeutic advances in drug safety, 9(9), 535–557.
O'Leary, L., Cooper, S. A., & Hughes‐McCormack, L. (2018). Early death and causes of death of people with intellectual disabilities: a systematic review. Journal of Applied Research in Intellectual Disabilities, 31(3), 325–342.
Royal College of Psychiatrists, 2016. Psychotropic drug prescribing for people with intellectual disability, mental health problems and/or behaviours that challenge: practice guidelines. Royal College of Psychiatrists.
Strydom, A., Dodd, K., Uchendu, N. and Wilson, S. (2020) Dementia and other disorders associated with ageing in people with intellectual disability. In S. Bhaumik & R. Alexander (Eds.), Oxford textbook of the psychiatry of intellectual disability (pp.83-90). Oxford University Press.
University of Bristol Norah Fry Centre for Disability Studies (2020). Learning Disabilities Mortality Review (LeDeR) programme. Annual report 2020. https://leder.nhs.uk/images/annual_reports/LeDeR-bristol-annual-report-2020.pdf
van Schrojenstein Lantman-de, H. M., & Walsh, P. N. (2008). Managing health problems in people with intellectual disabilities. Bmj, 337.
White, A., Sheehan, R., Ding, J., Roberts, C., Magill, N., Keagan-Bull, R., ... & Strydom, A. (2022). Learning from Lives and Deaths-People with a learning disability and autistic people (LeDeR) report for 2021.
World Health Organization. (2001). Healthy ageing–adults with intellectual disabilities: summative report. Journal of Applied Research in Intellectual Disabilities, 14(3), 256–275.
World Health Organization (WHO) (2019/2021) International Classification of Diseases, Eleventh Revision (ICD-11), https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO licence (CC BY-ND 3.0 IGO).
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Clinical data gathering, preparation, and analysis were performed by Ayomipo Amiola, Phil Temple and Ignatius Gunaratna. The first draft of the manuscript was written by Ayomipo Amiola, all authors commented on the first draft and subsequent versions of the manuscript. Ayomipo Amiola revised all drafts, and produced the final manuscript which was read and approved by all authors.
Corresponding author
Ethics declarations
Conflict of interest
All authors have no relevant financial or non-financial interests to disclose.
Ethics Approval
The study utilised routinely collected data from the admissions diagnostic assessment process. In accordance with NHS guidance on research, audit and service evaluation (NHS Health Research Authority, 2020), the project fulfilled criteria for service evaluation and hence did not require approval from a NHS Research Ethics Committee.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Amiola, A., Temple, P., Singh, A. et al. Psychiatry of Intellectual Disability in the Elderly: A Baseline Audit. J. Psychosoc. Rehabil. Ment. Health 10, 427–433 (2023). https://doi.org/10.1007/s40737-023-00363-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40737-023-00363-2